User profiles for Ana Ramírez de Molina
Ana Ramirez de MolinaIMDEA Food Institute Verified email at imdea.org Cited by 6254 |
Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives
…, A Rodríguez-Casado, A Ramírez de Molina - Nutrition …, 2013 - academic.oup.com
The population is aging. Over the coming years, the incidence of age-related chronic
diseases such as cancer is expected to continue to increase. Phytochemicals, which are non-…
diseases such as cancer is expected to continue to increase. Phytochemicals, which are non-…
Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy
A Ramírez de Molina, R Gutiérrez, MA Ramos, JM Silva… - Oncogene, 2002 - nature.com
Choline kinase (ChoK) and its product, phosphocholine (PCho), have been implicated in
human carcinogenesis. Inhibition of this enzyme has been shown to be an efficient antitumor …
human carcinogenesis. Inhibition of this enzyme has been shown to be an efficient antitumor …
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study
AR de Molina, J Sarmentero-Estrada… - The lancet …, 2007 - thelancet.com
Background Adequate prognostic markers to predict outcome of patients with lung cancer
are still needed. The aim of this study was to assess whether choline kinase alpha (ChoKα) …
are still needed. The aim of this study was to assess whether choline kinase alpha (ChoKα) …
[HTML][HTML] A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy
…, M Álvarez-Fernández, T Vargas, S Molina… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The alterations in carbohydrate metabolism that fuel tumor growth have been extensively
studied. However, other metabolic pathways involved in malignant progression, demand …
studied. However, other metabolic pathways involved in malignant progression, demand …
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
NMS Al-Saffar, H Troy, AR de Molina, LE Jackson… - Cancer research, 2006 - AACR
MN58b is a novel anticancer drug that inhibits choline kinase, resulting in inhibition of
phosphocholine synthesis. The aim of this work was to develop a noninvasive and robust …
phosphocholine synthesis. The aim of this work was to develop a noninvasive and robust …
Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression
AR de Molina, M Bánez-Coronel, R Gutiérrez… - Cancer research, 2004 - AACR
Breast cancer is still one of the most important tumors among women in industrialized countries.
Improvement in both understanding the molecular events associated with the disease …
Improvement in both understanding the molecular events associated with the disease …
Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells
M Gonzalez-Vallinas, S Molina, G Vicente… - Pharmacological …, 2013 - Elsevier
5-Fluorouracil (5-FU) is the most used chemotherapeutic agent in colorectal cancer. However,
resistance to this drug is relatively frequent, and new strategies to overcome it are urgently …
resistance to this drug is relatively frequent, and new strategies to overcome it are urgently …
Lipid metabolism and lung cancer
…, RS Martínez, E Casado, AR de Molina… - Critical reviews in …, 2017 - Elsevier
Lung cancer is currently one of the most serious health issues in developed and developing
countries. There are multiple available treatment options; however survival still remains very …
countries. There are multiple available treatment options; however survival still remains very …
Deciphering the human gut microbiome of urolithin metabotypes: association with enterotypes and potential cardiometabolic health implications
…, V Loria‐Kohen, A Ramírez‐de‐Molina… - Molecular nutrition & …, 2019 - Wiley Online Library
Scope The gut microbiota ellagitannin‐metabolizing phenotypes (ie, urolithin metabotypes [UMs])
are proposed as potential cardiovascular disease (CVD) risk biomarkers because the …
are proposed as potential cardiovascular disease (CVD) risk biomarkers because the …
Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy
…, G Reglero, A Ramírez de Molina - Nutrition and …, 2015 - Taylor & Francis
Cancer remains an important cause of mortality nowadays and, therefore, new therapeutic
approaches are still needed. Rosemary (Rosmarinus officinalis L.) has been reported to …
approaches are still needed. Rosemary (Rosmarinus officinalis L.) has been reported to …